Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial

Authors

Institutions

Publication Details

Journal
Journal of Gynecologic Oncology
Published
2025-01-01
DOI
https://doi.org/10.3802/jgo.2025.36.e117
Citations
3
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
6.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial

Kenichi Harano, Karen Allan, Alessandra Bologna, Sara Uggeri et al.
3 citations
Journal of Gynecologic Oncology
Endometrial and Cervical Cancer Treatments
6.17
article

Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial

Kenichi Harano, Karen Allan, Alessandra Bologna, Sara Uggeri, Janine Lombard, Roldano Fossati, Francesca Galli, Satoshi Nakagawa, Florian Heitz, Yoland Antill, B. Pardo, Shin Nishio, Luís Manso, Kazuhiro Takehara, Angiolo Gadducci, Maria-Pilar Barretina-Ginesta, Antonio Ardizzoia, Elena Biagioli, Cláudia Casanova, Chyong‐Huey Lai, Manuela Rabaglio, Yeh Chen Lee, Andrés Redondo, V Kolovetsiou-Kreiner, Innocenza Palaia, Edi Editta Baldini, Nicoletta Colombo, Chulmin Lee, E. Hudson, E. Au
article en
3 citations

Abstract

No abstract available for this paper.
Journal of Gynecologic OncologyVol. 36(4)
Kurume University (JP), University of Pisa (IT), IMT School for Advanced Studies Lucca (IT), The University of Sydney (AU), University of Milan (IT), Mario Negri Institute for Pharmacological Research (IT), Medical University of Graz (AT), Hospital Universitario La Paz (ES), University Hospital of Bern (CH), Chang Gung Memorial Hospital (TW), Research Institute Hospital 12 de Octubre (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Dongguk University Ilsan Hospital (KR), Institut Català d'Oncologia (ES), Alessandro Manzoni Hospital (IT), Peninsula Health (AU), National Health Insurance Service Ilsan Hospital (KR), Shikoku Cancer Center (JP), Duran i Reynals Hospital (ES), National Cancer Center Hospital East (JP), Kliniken Essen-Mitte (DE), Calvary Mater Newcastle Hospital (AU), Velindre Cancer Centre (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), National Health and Medical Research Council (AU), Monash University (AU), European Institute of Oncology (IT), University of Glasgow (GB), Sapienza University of Rome (IT), The University of Osaka (JP)
Roche, Chugai Pharmaceutical
Good health and well-being
Openalex Percentile: Top 4%
Endometrial and Cervical Cancer Treatments
6.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.